Session Details

[1S12a]Understanding the pathophysiology of neuropsychiatric disorders through mitochondrial and metabolic research

Mon. Mar 17, 2025 1:40 PM - 3:30 PM JST
Mon. Mar 17, 2025 4:40 AM - 6:30 AM UTC
Room 12
Oranizers :Hirotaka Nagai (Kobe University Graduate School of Medicine, Division of Pharmacology) and Mutsumi Yokota (Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine)
Mitochondria are intracellular organelles with diverse functions such as energy metabolism, signal transduction, calcium buffering, and organelle contact, and are involved in the regulation of neuronal function, cell death, and inflammation. Although the involvement of mitochondria in the pathophysiology of neurodegenerative and psychiatric disorders has been suggested, its mechanisms are largely elusive. This symposium will discuss mechanisms at the cellular level where maintenance of mitochondrial quality control or its failure induces or suppresses neuronal cell death, mechanisms at the individual level where environmental and genetic factors alter mitochondria and metabolism leading to cognitive and emotional disturbances, and prospects for drug discovery through mitochondrial function and metabolic control. Members of the Japanese Pharmacological Society and the Japanese Association of Anatomists will gather to overview the diverse physiological functions of mitochondria governing cell life and death, and brain functions, aiming to take a step toward a comprehensive understanding of the pathophysiology of neuropsychiatric disorders.

[[OD]1S12a-1]Mitochondrial morphology, function, and contacts with other organelles in dopaminergic neuron degeneration

Mutsumi Yokota, Koike Masato (Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine)
Comment()

[[OD]1S12a-2]Mitochondrial dynamics for the neuronal resilience to damage

Sumiko Kiryu-Seo (Nagoya University, Graduate School of Medicine)
Comment()

[[OD]1S12a-3]Metabolic mechanisms of social stress-related pathologies

Hirotaka Nagai, Tomoyuki Furuyashiki (Kobe University)
Comment()

[1S12a-4]Mitochondrial Factor Expression Changes as a Molecular Basis of CNS Disorders

Keiko Iwata, Norihito Shintani (Wakayama Medical University)
Comment()

[[OD]1S12a-5]Screening of novel mood stabilizers targeting calcium uptake of brain mitochondria

Mie Kubota-Sakashita1,2, Kawakami Hirochika1,2, Shirai Fumiyuki3, Kikuzato Ko3, Idei Akiko2, Matsuoka Seiji2, Yoshida Minoru2, Kato Tadafumi1 (1.Department of Psychiatry & Behavioral Science, Juntendo University Graduate School of Medicine, 2.Drug Discovery Seed Compounds Exploratory Unit, RIKEN Center for Sustainable Resource Science, 3.Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science)
Comment()